Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Perico
G Remuzzi

Showing results (251-260 of 551) with videos related to

Pageof 56
Sort By:
Contributions to Nephrology|June 9, 2001
Thrombotic microangiopathies in the intensive care unit: many questions, some answersP Ruggenenti, C Aros, G Remuzzi
Expert Opinion on Investigational Drugs|May 1, 1997
Recent developments in the management of membranous nephropathyA Schieppati, A Perna, G Remuzzi
Renal Physiology and Biochemistry|January 1, 1993
Interleukin-1 and glomerular mesangial cellsC Zoja, A Rambaldi, G Remuzzi
Nephron|January 1, 1987
What is the basis for the use of steroids in the treatment of idiopathic membranous nephropathy?S Garattini, T Bertani, G Remuzzi
Lancet (London, England)|November 22, 2001
Modulating the profit motive to meet needs of the less-developed worldA Schieppati, G Remuzzi, S Garattini
Journal of Nephrology|January 19, 2002
The role of the endothelium in hemolytic uremic syndromeC Zoja, M Morigi, G Remuzzi
Nephron|January 1, 1988
Steroids and cytotoxic drugs in the treatment of membranous glomerulopathyS Garattini, T Bertani, G Remuzzi
Seminars in Nephrology|June 1, 1985
Coagulation abnormalities in uremiaM Livio, A Benigni, G Remuzzi
Contributions to Nephrology|November 14, 2001
Renin-angiotensin system, proteinuria, and tubulointerstitial damageP Ruggenenti, C Aros, G Remuzzi
Contributions to Nephrology|November 2, 2001
Gene therapy to the kidneyS Tomasoni, G Remuzzi, A Benigni
Pageof 56

Showing results (251-260 of 551) with videos related to

Sort By:
Pageof 56
Contributions to Nephrology|June 9, 2001
Thrombotic microangiopathies in the intensive care unit: many questions, some answersP Ruggenenti, C Aros, G Remuzzi
Expert Opinion on Investigational Drugs|May 1, 1997
Recent developments in the management of membranous nephropathyA Schieppati, A Perna, G Remuzzi
Renal Physiology and Biochemistry|January 1, 1993
Interleukin-1 and glomerular mesangial cellsC Zoja, A Rambaldi, G Remuzzi
Nephron|January 1, 1987
What is the basis for the use of steroids in the treatment of idiopathic membranous nephropathy?S Garattini, T Bertani, G Remuzzi
Lancet (London, England)|November 22, 2001
Modulating the profit motive to meet needs of the less-developed worldA Schieppati, G Remuzzi, S Garattini
Journal of Nephrology|January 19, 2002
The role of the endothelium in hemolytic uremic syndromeC Zoja, M Morigi, G Remuzzi
Nephron|January 1, 1988
Steroids and cytotoxic drugs in the treatment of membranous glomerulopathyS Garattini, T Bertani, G Remuzzi
Seminars in Nephrology|June 1, 1985
Coagulation abnormalities in uremiaM Livio, A Benigni, G Remuzzi
Contributions to Nephrology|November 14, 2001
Renin-angiotensin system, proteinuria, and tubulointerstitial damageP Ruggenenti, C Aros, G Remuzzi
Contributions to Nephrology|November 2, 2001
Gene therapy to the kidneyS Tomasoni, G Remuzzi, A Benigni
Pageof 56